Cancer Centers Support Grants

 

To provide an organizational focus and stimulus for the highest quality cancer research that effectively promotes interdisciplinary cancer research aimed toward the ultimate goal of reducing cancer incidence, mortality and morbidity. The Cancer Center Support Grant (CCSG) provides the resources and infrastructure to facilitate the coordination of interdisciplinary programs across a broad spectrum of research from basic laboratory research to clinical investigation to population science. The CCSG supports salaries for scientific leadership of the Center, shared resources for funded center investigators, certain administrative costs, planning and evaluation, and developmental funds for new recruitments and feasibility studies.

Active 93.397 National Institutes of Health, Department of Health and Human Services B - Project Grants Fiscal Year 2016 Fiscal year 2016 will fund an estimated 271 total Centers that will include 69 COREs, 49 SPOREs and 103 Specialized Centers. In fiscal Year 2016, 217 total Centers were funded including 69 Centers, 50 SPOREs, and 98 Specialized Centers.
Fiscal Year 2017 Fiscal year 2017 will fund an estimated 234 total Centers that will include 69 Centers, 51 SPOREs and 90 Specialized Centers.
Fiscal Year 2018 Fiscal Year 2018 will fund 227 total Centers that will include 69 Centers, 51 SPOREs, and 90 Specialized Centers.
Fiscal Year 2019 Fiscal Year 2019 will fund 251 total Centers that will include 71 Centers, 52 SPOREs, 104 Specialized Centers, and 24 Planning.
Fiscal Year 2020 Fiscal Year 2020 funded 255 total centers that will include 71 Centers, 58 SPOREs, 94 Specialized Centers, and 32 Planning.
Fiscal Year 2021 Fiscal Year 2021 funded 2424 total centers that will include 71 Centers, 64 SPOREs, 84 Specialized Centers, and 23 Planning.
Fiscal Year 2022 Fiscal Year 2022 funded 255 total centers that will include 71 Centers, 66 SPOREs, 91 Specialized Centers, and 27 Planning.
Fiscal Year 2023 Fiscal Year 2023 will fund 260 total centers that will include 71 Centers, 66 SPOREs, 96 Specialized Centers, and 27 Planning.
Fiscal Year 2024 Fiscal Year 2024 will fund 267 total centers that will include 71 Centers, 66 SPOREs, 103 Specialized Centers, and 27 Planning. Public Health Service Act, Section 305(a), 410, 411, and 414, Public Law 78-410, 42 U.S.C. 241, as amended; Public Law 100-607, 42 U.S.C. 285, 285a and 285a-3; Public Law 99-500. Any nonprofit institution within the United States with a peer-reviewed cancer research base of 4.0 million dollars in direct costs may apply for a Cancer Center Support Grant. University, college, public agency or research institution in the U.S. The application requests documentation concerning the qualifications of the principal investigators and associates, pertinent budget information and justification for the support of this proposed grant. Methods to be utilized are outlined in the application materials. Costs will be determined in accordance with HHS Regulations 45 CFR, Part 75. Preapplication coordination is not applicable. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Method of Application: Form PHS-398 (Rev. June 2009) can be obtained from the grant.nih.gov/grants/forms.htm website (click on PHS-398). In addition, supplemental instructions for applications are contained in the Cancer Center Support Grant Guidelines,http://cancercenters.cancer.gov/grants_funding/index.html. Generally, the potential applicant should send a letter of intent to the National Cancer Institute, Office of Cancer Centers, submitting a CCSG application to the same address for review (see Guidelines for CCSGs). Completed applications should be submitted to the Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Grants are funded based on scientific merit, program relevance, and program balance and are made annually. Initial award provides funds for the first budget period (usually 12 months) and Notice of Grant Award (Form PHS 1533) indicates support recommended for the remainder of the project period, allocation of Federal funds by budget categories and special conditions, if any. Contact the headquarters or regional location, as appropriate for application deadlines Core Grants: Approximately 10 months. A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html and NIH Policy Manual Release date: February 7, 2012 http://oma.od.nih.gov/manualchapters/grants/54513/index.html). Same procedure as new applications. The major elements in evaluating applications include the following: (1) An adequate base of established programs of high quality in laboratory and clinical cancer research; (2) research activity in a variety of disciplines, and evidence of high degree of interdisciplinary coordination, interaction and cooperation among center members; (3) appropriate and adequate organization and facilities for the conduct and evaluation of center activities; (4) a qualified director with adequate authority; and (5) an adequate commitment of the parent institution or institutions to the cancer center. The center should be recognized as a major element within the organizational structure. In general, CCSGs do not support research projects directly but are used to enhance the ongoing cancer research and to strengthen the existing research base according to the "Policies and Guidelines Relating to the Cancer Center Support Grant." Not applicable. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal officials. Expenditures and other financial records must be retained for 3 years from the day on which the grantee submits the last financial status report for the report period. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Up to 5 years of support may be requested. Grants may be awarded up to 5 years based on competitive peer review. Method of awarding/releasing assistance: Letter. None. Shamala K. Srinivas
9609 Medical Center Drive
Seventh Floor, West Tower, 7W530, MSC 9750
Rockville, MD 20850 US
shamala@mail.nih.gov
Phone: 240-276-6442
Fax: 240-276-7682 http://cancercenters.cancer.gov/. 75-0849-0-1-550 (Project Grants) FY 22$592,362,558.00; FY 23 est $628,918,326.00; FY 24 est $645,212,080.00; FY 21$576,297,296.00; FY 20$654,880,416.00; FY 19$655,966,378.00; FY 18$564,391,000.00; - Range: $153,401 to $13,733,523 Average: $2,322,990 42 CFR 52; 45 CFR 75; PHS Grants Policy Statement, DHHS Publication No. (OASH) 90- 50,000, (Rev.) October 1, 1990. Not applicable.